Envoy Medical (COCH) Share-based Compensation (2022 - 2026)

Envoy Medical has disclosed Share-based Compensation across 5 years of filings, most recently posting $4.0 million for Q2 2026.

• In Q2 2026, Share-based Compensation rose 2608.26% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $4.0 million (changed N/A YoY), while the FY2025 annual figure was $2.3 million, up 2.08% from the prior year.
• Share-based Compensation came in at $4.0 million for Q2 2026 at Envoy Medical, up from $239000.0 in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $4.0 million in Q2 2026 to a low of -$288000.0 in Q4 2024.
• Average Share-based Compensation over 5 years is $1.3 million, with a median of $1.1 million recorded in 2022.
• Year-over-year, Share-based Compensation slumped 114.64% in 2024 and surged 2608.26% in 2026.
• Over 5 years, Share-based Compensation stood at $263000.0 in 2022, then soared by 648.19% to $2.0 million in 2023, then plunged by 114.64% to -$288000.0 in 2024, then jumped by 162.15% to $179000.0 in 2025, then soared by 2108.98% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $4.0 million in Q2 2026, $239000.0 in Q1 2026, and $179000.0 in Q4 2025.